Table 2B.
Endemic Resistance | ||
---|---|---|
Variable | aOR | 95% CI |
Ciprofloxacin, resistance║ | ||
West | 2.6 | 2.4–2.9 |
Midwest | 10.8 | 8.4–13.9 |
Northeast/South | 2.5 | 2.2–2.9 |
Penicillin, resistance¶ | ||
West | 2.1 | 1.9–2.4 |
Midwest | 4.0 | 3.2–5.0 |
Northeast/South | 2.3 | 2.0–2.6 |
Tetracycline, resistance# | ||
West | 2.5 | 2.3–2.8 |
Midwest | 5.4 | 4.5–6.4 |
Northeast/South | 2.1 | 1.9–2.4 |
aOR = adjusted odds ratio; CI = confidence interval;
GISP = the Gonococcal Isolate Surveillance Project;
MIC = minimum inhibitory concentration; MSM = men
who have sex with men; MSW = men who report
having sex exclusively with women
All models adjusted for age, region, race/ethnicity, antimicrobial use, travel history, HIV infection, prior gonococcal infection, and the interaction between gender of sex partner & region.
MIC ≥ 1 μg/ml
MIC ≥ 2 μg/ml or β-lactamase positive
MIC ≥ 2 μg/ml